Allurion Technologies Inc. (ALUR)
NYSE: ALUR · Real-Time Price · USD
1.170
-0.080 (-6.40%)
At close: Feb 27, 2026, 4:00 PM EST
1.180
+0.010 (0.85%)
After-hours: Feb 27, 2026, 7:59 PM EST
Allurion Technologies Revenue
Allurion Technologies had revenue of $2.66M in the quarter ending September 30, 2025, a decrease of -50.48%. This brings the company's revenue in the last twelve months to $17.21M, down -50.49% year-over-year. In the year 2024, Allurion Technologies had annual revenue of $32.11M, down -39.94%.
Revenue (ttm)
$17.21M
Revenue Growth
-50.49%
P/S Ratio
0.83
Revenue / Employee
$125,606
Employees
137
Market Cap
14.37M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 32.11M | -21.36M | -39.94% |
| Dec 31, 2023 | 53.47M | -10.74M | -16.73% |
| Dec 31, 2022 | 64.21M | 25.97M | 67.91% |
| Dec 31, 2021 | 38.24M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionALUR News
- 4 days ago - Allurion Announces Exercise of Warrants for $3.0 Million in Gross Proceeds - Business Wire
- 5 days ago - Allurion Receives U.S. FDA Approval - Business Wire
- 25 days ago - Allurion Announces Partnership to Offer Combination Therapy with Mounjaro® (tirzepatide) at Discounted Prices - Business Wire
- 6 weeks ago - Allurion Announces Preliminary Fourth Quarter and Full-Year 2025 Results - Business Wire
- 3 months ago - Allurion Announces Initial Results on Combining the Allurion Program With Low-Dose Tirzepatide to Optimize Muscle Mass and GLP-1 Adherence - Business Wire
- 3 months ago - New Peer-Reviewed Publication Demonstrates Superior Weight Loss and Improved Body Composition with the Allurion Smart Capsule Combined with Lifestyle Intervention Compared to Lifestyle Intervention Alone - Business Wire
- 3 months ago - Allurion Announces Strategic Distribution Partnership with ProSurg Medical in Brazil to Pioneer New Approach Focused on Metabolically Healthy Weight Loss - Business Wire
- 3 months ago - Allurion Technologies Inc. (ALUR) Q3 2025 Earnings Call Transcript - Seeking Alpha